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Abstract
Human bone marrow cells were sequentially fractionated by three
negative selection steps to remove adherent cells and Fc receptor-
bearing cells, followed by immune adsorption (panning) to deplete
maturing cells that react with a panel of monoclonal antibodies.
This nonadherent Fc receptor and antibody negative fraction
could be further enriched by a positive selection "panning" step,
using an antibody to HLA-DR antigen; 12-27% of the cells
formed erythroid burst-forming unit (BFU-E), erythroid colony-
forming unit, granulocyte-monocyte colony-forming unit, and
erythroid and granulocyte and/or monocyte colony-forming unit-
derived colonies with recovery of 0.5-1% of the cells and 20-
100% of the colony-forming cells.
Sequential fractionation resulted in increasing dependence
of a subset of BFU-E-derived colonies on exogenous burst-pro-
moting activity (BPA) for proliferation in culture, but the most
enriched progenitor fraction still contained a proportion of ac-
cessory cell or BPA-independent BFU-E that responded to either
natural or biosynthetic erythropoietin when added to cultures on
day 0 in the absence of BPA. If the addition of erythropoietin
was delayed until day 3, the data suggest that this population of
BFU-E either died or became unresponsive to erythropoietin.
Delayed addition of erythropoietin to cultures of enriched pro-
genitors provided a sensitive BPA assay, since BPA-independent
but erythropoietin-responsive BFU-E were eliminated. The sur-
viving BFU-E that were dependent for their proliferation on the
presence of both BPA and erythropoietin showed a characteristic
dose response to increasing BPA concentrations.
Introduction
Hemopoietic progenitors depend on specific glycoprotein growth
factors for their survival, proliferation, and terminal differentia-
tion in vitro. Insight into the regulation of hemopoiesis at a
cellular level requires purification of both progenitors and he-
mopoietic growth factors (HGFs).' To date, at least three human
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1. Abbreviations used in this paper: Ab- and AbV, cells without and with
antigens recognized by a panel of monoclonal antibodies, respectively;
Ad- and Ad', plastic nonadherent and adherent cells, respectively; BFU-
E, erythroid burst-forming unit; BPA, burst-promoting activity; CFU-
E, erythroid colony-forming unit; CFU-GM, granulocyte-monocyte CFIJ;
CFU-MIX, erythroid and granulocyte and/or monocyte CFU; CM, con-
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HGFs have been purified to homogeneity and their genes cloned
(1-5): Granulocyte-macrophage colony-stimulating factor (GM-
CSF) stimulates the formation of colonies derived from gran-
ulocyte and/or monocyte progenitors (CFU-GM). We have re-
cently demonstrated (6) that purified recombinant GM-CSF also
has burst-promoting activity (BPA) for erythroid burst-forming
units (BFU-E) and stimulates the formation of colonies derived
from multipotent progenitors (CFU-MIX); erythroid-potentiat-
ing activity (EPA) (2, 3) increases BFU-E and erythroid colony-
forming unit (CFU-E) numbers above background in a low
serum assay; and erythropoietin (EP) (4, 5) acts on committed
erythroid progenitors and is essential for the terminal maturation
of erythroid cells.
Progenitor purification is necessary because accessory
"helper" cells present in unfractionated bone marrow produce
factors that result in significant background noise in colony-
forming assays for growth factor activity. Progenitors comprise
<1% (usually <0.5%) of human bone marrow cells. Because of
the heterogeneity ofbone marrow tissue, attempts to purify them
using physical parameters have been only partially successful
(7, 8), although murine CFU-E have been greatly enriched (9).
Monoclonal antibodies and/or lectins have been used with more
success for purifying mouse (10) and human ( I1-14) progenitors
using negative and/or positive selection by complement lysis
(13, 14), immune rosetting (14), or fluorescence-activated cell
sorting (FACS) (10, 11, 13) techniques. While significant en-
richment using these methods has been obtained, disadvantages
include nonspecific cell loss with poor progenitor recovery, and
long sorting times with the FACS that make difficult the selection
of these rare cells in sufficient numbers for further study. Im-
munoadsorption to plastic dishes (panning) combined with the
FACS has been used to partially enrich for murine bone marrow
progenitors (15), and recently we have shown that the progenitors
present in human fetal liver can be greatly enriched with excellent
recovery using immunoadsorption to immunoglobulin-coated
plates ( 16).
In this report, we show that sequential fractionation ofhuman
bone marrow cells results in increasing dependence of BFU-E
on an exogenous source of BPA for proliferation in culture.
Panning, using negative selection with a combination of mono-
clonal antibodies, followed by positive selection with an antibody
ditioned medium; DR' and DR-, cells expressing or not expressing HLA-
DR antigens, respectively; EP, erythropoietin; EPA, erythroid-poten-
tiating activity; FACS, fluorescence-activated cell sorting; Fcr- and Fcr+,
cells without and with receptors for the Fc portion of immunoglobulins,
respectively; FCS, fetal calf serum; GCT, giant cell tumor, GCT-CM,
GCT cell line-conditioned medium; GM-CSF, granulocyte-monocyte
colony-stimulating factor; HGF, hemopoietic growth factor; IMDM, Is-
cove's modified Dulbecco's medium; Mo-CM, Mo T lymphoblast cell
line-conditioned medium; REC, recombinant EP; U, unfractionated Fi-
coll-Hypaque bone marrow mononuclear cells.
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to HLA-DR antigens, can greatly enrich for progenitor cells with
good recovery. Among these progenitors are two distinct BFU-
E populations. One subset is initiated into terminal differentia-
tion by EP alone; the second and somewhat larger subset requires
both BPA and EP to differentiate. (Indeed, this class of BFU-E
cannot survive 3 d in culture ifBPA is withheld.) Manipulation
of these subsets by delayed addition of either partially purified
human urinary or recombinant erythropoietin (REC) to enriched
progenitors thereby provides a method to perform a sensitive
BPA assay with no or minimal background colony formation.
Methods
Bone marrow samples. Normal human bone marrow was obtained by
aspiration from adult volunteers. Approximately 5-15 ml from 1 to 2
aspirations was collected into sterile syringes containing preservative-
free heparin.
Cell separation procedures. The marrow suspensions were separated
over Ficoll-Hypaque (1.077 g/cu cm) (Pharmacia Fine Chemicals, Pis-
cataway, NJ) at 400 g for 40 min at 200C and the interface mononuclear
cells collected, washed three times, and resuspended in Iscove's modified
Dulbecco's medium (IMDM) containing 20% fetal calf serum (FCS).
The cells were incubated in 100-mm tissue culture dishes (Lux, Miles
Laboratories, Naperville, IL) overnight at 370C and the nonadherent
cells (Ad-) removed with two gentle washes and centrifuged.
Fc receptor-positive cell depletion. In some experiments, the Ad- cells
were resuspended in phosphate-buffered saline (PBS) containing 5% FCS
and incubated on immunoglobulin-coated 100-mm plastic Petri dishes
for I h at 40C. Fc receptor negative (Fcr-) cells were removed with two
gentle washes and the cells centrifuged.
Immunoadsorption to immunoglobulin-coated plates (panning). The
bone marrow cells were incubated at 40C for 30 min with previously
determined optimal concentrations of either Leu I and 5b (Becton-
Dickinson Monoclonal Centre Inc., Mountain View, CA) to label T
lymphocytes or a panel of 10-12 monoclonal antibodies directed against
myeloid, erythroid, and lymphoid maturation antigens (Table I). The
cells were washed twice in IMDM containing 2% FCS and once in PBS/
5% FCS, resuspended at 5-6 X 106/ml in PBS/5% FCS, and 4-5-ml
aliquots were incubated at 40C for I hon 100-mm plastic bacteriological
petri dishes (Fisher Scientific Co., Pittsburgh, PA) that had been previously
coated with rabbit anti-mouse immunoglobulin (see below). The non-
adherent cells (T- [Leu 1/5b]) or antibody-negative cells (Ab- [multiple
antibodies]) were removed and washed twice by gently swirling, tilting,
and decanting, and then a second incubation on another antibody-coated
plate was carried out to ensure removal of all antibody labeled cells. In
some experiments, the Ab- cells were incubated with a monoclonal an-
tibody to HLA-DR antigen (Becton-Dickinson & Co., clone L243),
washed, and incubated at 40C for 1 h on a third immunoglobulin-coated
plate. Nonadherent HLA-DR-negative cells were removed with two
gentle washes. The plates were then washed three times and the adherent
HLA-DR-positive cells were removed by vigorous pipetting using 10 ml
of IMDM/2% FCS. Most of the adherent cells detached with this pro-
cedure, but occasionally it was necessary to remove the remaining cells
with a rubber policeman. Cytocentrifuge preparations of the different
cell fractions were stained with Wright-Giemsa for differential counting.
Preparation of immunoglobulin-coated plates. Panning was carried
out by minor modifications of the method of Wysocki and Sato (21).
100 X 15-mm polystyrene bacteriological petri dishes (Fisher Scientific
Co.) (catalogue 8-751-12) were incubated at room temperature in 10 ml
affinity-purified rabbit anti-mouse IgG, and A & M heavy and light chain
immunoglobulin (Zymed Laboratories Inc., San Francisco, CA) diluted
to 10 gg/ml in PBS. After 40 min, the plates were washed three times
in PBS and then incubated at 4°C in 5 ml PBS/l% FCS until required.
Culture procedures. The bone marrow cells were cultured in a mixture
containing 30% FCS, 1% bovine serum albumin (BSA) (Sigma Chemical
Co., St. Louis, MO), 10' M mercaptoethanol (Sigma Chemical Co.),
penicillin/streptomycin, and 0.9% methyl cellulose. Mo TIymphoblast
Table I. Monoclonal Antibodies Used to Fractionate Bone Marrow
Antibody Specificity Source and reference
Leu I T lymphocyte Becton-Dickinson
& Co.
Leu 5b T lymphocyte, some Becton-Dickinson
NK cells & Co.
Leu 9 T lymphocytes Becton-Dickinson
& Co.
Leu 12 B lymphocytes Becton-Dickinson
& Co.
Campath I T and B lymphocytes Hale et al. (17)
TG I Myeloid maturation Beverly et al. ( 12)
Leu Ml Monocytes, granulocytes Becton-Dickinson
& Co.
Leu M3 Monocytes Becton-Dickinson
& Co.
Mo I Monocytes, myeloid Todd et al. (18)
maturation, NK cells
My 8 Monocytes, myeloid Griffin et al. (19)
maturation
YTH 89.1.8 Glycophorin A H. Waldmann
LICR.LON.R 18 Glycophorin A Edwards (20)
L243 HLA-DR Becton-Dickinson
& Co.
NK, natural killer.
cell line-conditioned medium (Mo-CM) (22) prepared from the Mo T
lymphoblast cell line was kindly provided by Drs. D. Golde and J. Gasson,
UCLA School of Medicine, Los Angeles, CA, and was added with GCT-
cell line-conditioned medium (GCT-CM) (23) (Gibco, Grand Island,
NY) at 10% ofthe final volume (5% each) as a source ofBPA/GM-CSF.
In one experiment, highly purified recombinant GM-CSF was used in-
stead. Either human urinary EP (Terry Fox Laboratories, Vancouver,
British Columbia, Canada) at 2 U/ml, or human REC obtained from
transfected COS or CHO cells (5) was added to the cultures on day 0 or
day 3. The day 3 additions were made either directly to the methylcellulose
cultures or, in some experiments, to cells that had been suspended in
IMDM/2% FCS with Mo/GCT CM in a tissue culture incubator at 370C/
5% CO2 for 3 d. The total volume of these suspension cultures was 0.25
ml, and on day 3, 1 ml ofthe methylcellulose culture mixture was added
to the suspension cultures and the mixture plated and returned to the
incubator. The final concentration of cells was 1,000-50,000 cells/ml
depending on the degree ofenrichment expected forthe different fractions.
The cells were plated in 0.5-ml duplicates in flat-bottomed 24-well tissue
culture plates (Linbro, Flow Laboratories Inc., McLean, VA) and in-
cubated at 37°C in a high humidity 5% C02, 95% air incubator. CFU-
E were counted on day 7 and BFU-E, CFU-GM, and CFU-MIX, com-
prising granulocytes and/or monocytes and erythroid cells, were counted
on day 14.
Calculation ofprogenitor recovery. The number of colonies present
in the Ficoll-Hypaque mononuclear cell fraction cultured in the presence
of Mo-GCT CM was taken as 100%, and recovery of progenitors in all
fractions related to this by multiplying colony number in each fraction
by the cumulative proportion of cells recovered after that fractionation
step, i.e., recovery = colony number X proportion of cells recovered
X 100 + colony number in the unfractionated sample (+ Mo/GCT).
Results
Effect of sequential fractionation ofhuman bone marrow cells
on colony growth. Fig. 1 shows the recovery and enrichment
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Figure 1. Fractionation of human bone marrow. U were sequentially
fractionated by overnight adherence to plastic (Ad-); depletion of cells
with receptors for the Fc portion of immunoglobulin by adherence
(panning) to immunoglobulin coated petri dishes (Fcr-); and a second
panning step to remove cells reacting with a panel of monoclonal anti-
bodies recognizing maturation antigens (Ab-). Each fraction was cul-
tured for progenitor colony growth without (open bars) and with
(hatched bars) Mo/GCT CM, and EP was added day 0. The bar dia-
gram indicates colony recovery as percentage of the colonies recovered
in U cultured with Mo/GCT (100%). CFU-GM (upper panel) are al-
most completely dependent on Mo/GCT for proliferation in all frac-
tions. In marked contrast to CFU-E (lower panel), BFU-E show in-
creasing Mo/GCT dependence as the fractionation proceeds. U and
Ab- colony number per 101 cells plated is shown on the right of the
appropriate bars.
observed in a representative experiment when Ficoll-Hypaque
separated mononuclear cells (U) were sequentially depleted of
monocytes (Ad-), Fc receptor-bearing cells (Fcr-), and maturing
precursor cells (Ab-), and each fraction was cultured in the pres-
ence or absence of Mo/GCT CM as a source of HGF. Human
urinary EP was added on day 0. Recovery for all three progenitor
classes was >70% through the first three steps, but dropped to
-40% after antibody panning. CFU-GM-derived colonies show
marked dependence on Mo/GCT for proliferation in culture,
even in the culture of the unfractionated cell population before
monocyte depletion. In contrast, CFU-E were not dependent
on Mo/GCT for proliferation in this assay. A subset of BFU-E
showed increasing dependence on Mo/GCT CM as monocytes,
Fc receptor-bearing cells and maturing cells, including lympho-
cytes, were removed. Note that even the final Ad- Fcr- Ab-
fraction contained a proportion of BFU-E that were responsive
to EP in the absence ofMo/GCT CM. A 14-17-fold enrichment
was obtained, with 3.5% of the final fraction capable of colony
formation. Representative cytospin differential counts of the cell
fractions are shown in Table II. The majority of adherent cells
are monocytes; Fc receptor-positive cells are mostly lymphoid
cells, but include myeloid precursors and a significant number
of monocytes; and antibody-positive cells comprise myeloid
precursors, lymphocytes, and variable numbers of erythroid
precursors and monocytes. The final Ad- Fcr- Ab- fraction is
enriched for myeloblasts and large mononuclear cells with
prominent nucleoli, indented or oval nuclei, and basophilic fairly
abundant cytoplasm. Variable numbers of promyelocytes/my-
elocytes contaminate this fraction.
Enrichment ofprogenitors using combined negative andpos-
itive selection. Fig. 2 shows the enrichment and recovery observed
when bone marrow cells were depleted of adherent cells and
maturing precursors, followed by a second panning step in which
adherent HLA-DR-positive cells were detached from the plastic
dishes after removal ofthe HLA-DR-negative nonadherent cells.
60-100% ofprogenitors were recovered in the HLA-DR-positive
fraction. Virtually all CFU-GM and BFU-E were recovered in
the positive fraction in contrast to CFU-E, of which a minority
(10%) were recovered in the negative fraction. These results are
similar to those previously reported using FACS analysis (24).
All progenitor classes were greatly enriched, with BFU-E com-
prising 16%, and CFU-E and CFU-GM 5.7 and 5.5% ofthe final
fraction, respectively (39-65-fold enrichment). The enrichment
observed in this and two other experiments is summarized in
Table III. A similar pattern of growth dependence on Mo/GCT
was observed for the three progenitor classes to that shown in
Fig. 1, and even the highly enriched HLA-DR-positive fraction,
plated at very low density (1,000 cells/ml) contained BFU-E
responsive to EP alone (data not shown).
Effect ofdelaying the addition ofEP on BFU-E. When EP
was added to either unfractionated or highly enriched bone mar-
Table I. Cytocentrifuge Differential Counts (%)
M E
Experiment I e i p L Mo LMC B
1 U 46 6 16 3.5 19 2.5 4.5 2.5
Ab- 5.5 8.5 2 0.5 5.5 1.5 68 8.5
2 U 24 12 14 44 4 0 2
Ab- 14 16 7 26 0 29 8
Ad+ 2 13 85
Fcr' 13 4 1 55 26 1 0
Ab+ 19 6 3 67 2 2 1
Results from two representative experiments in which 200 cells from each fraction were counted. U and Ab- fractions were separated as indicated
in Fig. 1. Ad+ and Fcr' cells were removed using a rubber policeman and AbV cells by repeated pipetting. M, myeloid; 1, late precursors-myelo-
cytes and metamyelocytes; e, early precursors-promyelocytes; E, erythroid; i, intermediate and late normoblasts; p, pronormoblasts and early nor-
moblasts; L, lymphoid; Mo, monocyte; LMC, large basophilic mononuclear cells; B, blast.
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Figure 2. Enrichment of progenitors in human bone marrow. Progeni-
tor recovery and colony growth (see Fig. 1) are shown for HLA-DR
positive (DR') and negative (DR-) cells obtained after sequential frac-
tionation (see Methods). EP was added on day 0. 60-100% of progeni-
tors were recovered; virtually all the BFUJ-E and CFU-GM were in the
DR-positive fraction, whereas a minority of CFU-E were negative.
Marked enrichment was obtained, especially for BFUJ-E in this experi-
ment, but note that this enriched HLA-DR' BFU-E population con-
tained progenitors responsive to EP alone (open bar).
row BFU-E cultures on day 0 (Fig. 3, upper panel), considerable
"background" BFU-E-derived colony formation was observed
in both fractions. The background was unusually low for un-
fractionated cells in this experiment, and the results depicted in
Fig. 1 are more typical. In contrast, when exposure to EP was
delayed until day 3 and added either directly to the methylcel-
lulose cultures (middle panel) or to preincubated suspension
cultures, which were then plated in methylcellulose (lower panel),
background colony formation in the absence of Mo/GCT CM
was reduced, markedly in the highly enriched fractions. Results
from the particular experiments depicted in Figs. 2 and 3 do
not show increasing dependence of enriched progenitors on Mo/
GCT, as illustrated in Fig. 1. We therefore analyzed a larger
series of experiments to investigate the effect of sequential de-
pletion more thoroughly. The results for a series of 10 experi-
ments comparing day 0 to day 3 EP addition are summarized
in Fig. 4, with the ordinate showing the ratio of BFU-E-derived
colonies observed without or with Mo/GCT CM. In this series
of experiments, adherent cells, Fc receptor-positive cells, and T
lymphocytes (Leu 1, 5b positive) were sequentially removed. It
is evident from Fig. 4 that unfractionated cells to which EP was
added on day 0 usually showed a response to Mo/GCT. Dielayed
addition of EP enhances this BPA dependence in all fractions,
and BFU-E in Fcr- and T cell-depleted fractions are almost
completely dependent on exogenous BPA for proliferation in
culture.
Comparison ofthe effect ofhuman urinary and recombination
EP on enriched progenitors. It was possible that the BFU-E-
derived colonies observed in the highly enriched progenitor
fractions without added Mo/GCT CM were responding to BPA
contaminating the partially purified human urinary EP used in
these experiments. The EP gene has recently been cloned and
expressed in COS cells (5). We therefore compared the effect of
human urinary EP with REC on BFU-E-derived colony for-
mation in such enriched fractions. Fig. 5 showed that both hu-
man urinary and REC added at 2 U/ml on day 0 (upper panel)
stimulated similar numbers of BFU-E-derived colonies in the
presence or absence of Mo-CM. Since mock COS CM has no
BPA (data not shown), these data suggest that a proportion of
BFU-E respond to EP alone. Both types ofEP induced very low
background BFU-E-derived colony formation when the addition
of EP was delayed until day two (lower panel).
We therefore wished to determine whether the fraction of
BFU-E that were able to respond to day 0 addition ofEP alone
could survive in its absence if BPA was substituted instead.
Hence, we compared (Fig. 6) the number of BFU-E-derived
colonies induced by day 0 EP alone (abscissa) to the decline in
colony number (A) observed in the presence of BPA when EP
was added on day 3 compared with day 0 (ordinate). Linear
regression analysis of the results of eight experiments (13 ob-
Table III. Enrichment ofProgenitors Using Combined Negative and Positive Selection
Derived colonies/105
Exp. Cell fraction BFU-E CFU-E CFU-GM CFU-MIX CFCO Recovery
1 U 250 108 140 NDt
DR+ 16,300 5,700 5,500 0 27.5 61-100
DR- 400 1,870 0 0
2 U 118 98 100 4
DR+ 5,000 2,500 4,200 100 11.7 25-43
DR- 200 1,300 80 0
3 U 142 72 212 6
DR+ 5,000 2,800 7,800 200 15.6 18-20
DR- 0 20 0 0
Enrichment obtained for three experiments, including exp. 1, the results of which are shown in more detail in Fig. 2, in which bone marrow cells
were sequentially fractionated to remove adherent cells and antibody-positive cells and then separated on the basis of HLA-DR expression.
* CFC, total colony-forming cells as a percentage of cells plated.
* ND, not done. Colony density was too high in this experiment to confidently enumerate CFU-MIX.
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Figure 3. Effect of delayed EP addition on BFU-E derived colonies:
recovery of BFU-E before (U) and after (Ab-) sequential fractionation.
When EP was added on day 0 to methylcellulose cultures (upper
panel), a proportion (3-I) of BFU-E-derived colonies formed in the
absence of Mo/GCT (open bars). However, when EP addition to ei-
ther methylcellulose cultures (middle panel) or suspension cultures
(lower panel) was delayed until day 3, very few BFU-E were observed
in the Ab- fraction in the absence of Mo/GCT. In this experiment, re-
covery in both day 3 EP additions is related to U + Mo/GCT day 0
EP. 176 BFU-E-derived colonies/105 cells formed in this fraction.
servations) showed a significant correlation (r = 0.88, P < 0.0001
by a two-sided t test [25]) between the BFU-E-derived colony
numbers for the individual experiments, whether the EP used
was natural or biosynthetic, or whether EP was added on day 3
directly to methylcellulose cultures or to suspension cultures.
These data suggest that the BPA-independent BFU-E population
is the same subset of BFU-E that require EP from the initiation
of progenitor culture. They will not survive 72 h in BPA alone.
BFU-E dose response to Mo/GCT CM. The dependence of
a subset of highly enriched Abe BFU-E on an exogenous source
ofBPA when EP addition was delayed suggested that this would
provide a useful assay for BPA. Pooling data from five experi-
ments, Fig. 7 shows a normalized dose response of BFU-E to
increasing concentrations of Mo-CM. A plateau was observed
at 5% CM, and the mean maximal colony number at 10% Mo-
Figure 4. Summary of the
effect of delayed EP addi-
o 1.0 tion on sequentially frac-
+ 0 8 tionated bone marrow. In
0.8 this series of 10 experi-
.o 0.6 ments, the final step con-
M 0.4 \ sisted of panning with two
W EP (Day 0) antibodies to T lympho-
cytes (Leu l/5b), and the
U Ad- Fcr- Leu graph shows the ratio of
1/5b- BFU-E-derived colonies
observed without or with
Mo/GCT for each fraction when EP was added on either day 0 (solid
circles) or day 3 (open circles). In all fractions, delay of the addition of
EP increased dependence on Mo/GCT and the day 3 addition Fcr-
and Leu l/5b- fractions were almost totally dependent on Mo/GCT
for proliferation (ratio < 0.1). Colony number per lO U ranged from
17 to 142 BFU-E/105 and recovery from 40 to 122%.
Colonies/
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Figure 5. Comparison of the effect of human urinary (Terry Fox Lab-
oratories) and REC on Ab--enriched BFU-E. The histogram shows re-
covery of enriched Abe bone marrow BFU-E in relation to U + Mo-
CM taken as 100% (not shown). BFU-E-derived colony number in
this control fraction was 120/105. Both sources of EP stimulated simi-
lar numbers of BFU-E-derived colonies in the presence or absence of
Mo-CM, and very few colonies were observed in the absence of Mo-
CM when EP addition was delayed until day 2 (open bars). CM from
mock transfected COS cells had no EP or BPA activity.
CM was 1,415 BFU-E/105 Abe BM cells (range 320-1,970).
Background colony formation was very low in the absence of
Mo-CM (mean 75, range 13-180 BFU-E/105 cells).
Effect ofincreasing REC concentration on CFU-GM-derived
colonies. In view of the hypothesis that EP can act as an instruc-
tive molecule and promote stem cell or bipotent progenitor
commitment to erythropoiesis at the expense of other haemo-
poietic lineages, we carried out a dose response on highly enriched
progenitors using REC (Fig. 8). We have recently shown that
recombinant GM-CSF has BPA (6), and we used highly purified
(specific activity 1-4 X 107 U/mg in an agar bone marrow CFU-
GM assay [1]) recombinant GM-CSF as the source of BPA for
this experiment to define the culture conditions as carefully as
possible. The result showed no inhibitory effect of increasing
a
0
E
m
..c
0
0
0
2000
1500
1000
500 1000 1500 2000
Colonies (without BPA)
2500
Figure 6. Relationship of EP to BPA requirement of a subset of BFU-
E. The ordinate represents the difference (A) between the frequencies
of BFU-E-derived colonies that appear in the presence of BPA when
EP is added either on day 0 or day 3 to duplicate cultures of a BM
progenitor concentrate. The abscissa represents the colonies that ap-
pear in the same cultures in the absence ofBPA when EP is added on
day 0. Linear regression analysis reveals a close correlation (r = 0.88,
P < 0.0001 by a two-sided t test).
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Figure 7. Normalized Mo-CM dose responses of enriched (Ab-) bone
marrow BFU-E after delayed addition of EP. Data were pooled from
five experiments and shows mean± I SD. There are very few BFU-E-
derived colonies (mean 75, range 13-180/105 cells) in the absence of
Mo-CM and a plateau was observed at 5% Mo-CM. The maximal
BFU-E number at 10% Mo-CM was 1,415 (range 320-1,970)/101
cells.
doses of erythropoietin on CFU-GM-derived colony numbers.
At very high doses, the REC is apparently inhibitory, but this
may have been due to the larger volume necessary to incorporate
this dose in the cultures, or to other inhibitory components pres-
ent in the EP preparation.
Discussion
In this report, we demonstrate that normal human bone marrow
cells can be sequentially depleted of BPA-producing accessory
cells to provide a final nonadherent, Fc receptor and multiple
antibody-negative cell fraction that is considerably enriched for
progenitors. A second positive selection panning step using an
antibody to HLA-DR antigens results in further enrichment,
with total colony-forming cells comprising 12-27% of this frac-
tion, and progenitor and cell recovery, 19-100% and 0.5-1%,
respectively. To our knowledge, this is the highest concentration
of a workable population of normal human bone marrow pro-
genitors achieved to date.
Previous attempts to enrich for progenitors in bone marrow
have been beset with difficulties relating mainly to progenitor
yield. Thus, although the FACS can be used in conjunction with
BFU-E
CFU-GM
Erythropoietin (U/mr)
Figure 8. Dose response of
enriched bone marrow pro-
genitors to REC. Although
a progressive linear BFU-E
response was observed from
0.63 to 4.0 U/ml, CFUJ-
GM-derived colony num-
bers remained constant over
this range. Cultures con-
tained 1 ng/ml recombinant
GM-CSF (maximal stimula-
tion for this material) and 5 X 103 Ab- bone marrow cells/ml. EP was
added on day 0.
monoclonal antibodies to select positively for progenitors (1 1,
12), impractically prolonged sorting times are necessary to select
rare cells, and yields are often reduced (20-50%). Complement
lysis is associated with significant nonspecific cell loss (13), and
normal bone marrow progenitors may be sensitive to nonspecific
damage by CrCl3-coupled erythrocytes that are used for immune
rosetting. Immunoadsorption to antibody-coated plates (pan-
ning) can be used for negative and positive selection (21), and
is a simple, reproducible procedure that can provide highly en-
riched progenitor fractions, with moderately reduced yields. In
this respect, our results are not as good as those we obtained
when separating human fetal liver progenitors (yields 60-100%)
(16), but fetal liver cells are two- to fivefold enriched for pro-
genitors compared with bone marrow, and do not require such
extensive fractionation. The results do, however, compare very
favorably with other attempts to enrich human bone marrow
progenitors (12, 14, 26).
The sequential fractionation data demonstrate that the ma-
jority of bone marrow BFU-E require a source of exogenous
BPA for their survival in vitro. In unfractionated marrow, the
BPA requirement for these BFU-E is partially met by adherent
cells, Fcr' cells, and T lymphocytes. The increasing dependence
ofthis subset ofBFU-E in sequentially fractionated bone marrow
cells on an exogenous source ofBPA supports previous evidence
and recent data from this laboratory (14) that bone marrow
monocytes (14, 27-29), Fc receptor-bearing cells (14), and T
lymphocytes (14, 29-32) produce BPA or collaborate in its pro-
duction. However, even highly enriched progenitor fractions
contain a fraction of BFU-E responsive to EP in the absence of
BPA and unaffected by accessory cell depletion. That this BFU-
E population is responsive to EP and not a BPA contaminant
in human urinary EP is shown by the similar results obtained
when REC was used. Furthermore, the number of day 0 EP-
responsive BFU-E-derived colonies correlates significantly with
the decline in BFU-E observed when the addition ofEP is delayed
until day 3 in the presence ofMo/GCT CM. This suggests that
once BFU-E have become EP sensitive, they require exposure
to the hormone for survival and terminal differentiation. They
appear to die or become unresponsive in its absence. Thus, al-
though most BFU-E survive in the presence of BPA for 3 d, a
smaller proportion are BPA independent and require exposure
to EP for terminal differentiation to occur. We presume that the
former represent immature, and the latter, mature, BFU-E. The
results support previous evidence suggesting that BFU-E are
heterogeneous with respect to their BPA and EP responsiveness
(33, 34), and are consistent with recent short-term bone marrow
liquid culture results suggesting that day 15 BFU-E are sensitive
to EP (35).
The EP responsive BPA-independent BFU-E population has
made it difficult to assay for BPA in the past, since EP is essential
for terminal maturation of all erythroid colonies. When EP is
added to cultures on day 0, the result is a high background of
BPA-independent BFU-E-derived colonies that are indistin-
guishable from the BFU-E-derived colonies forming in the pres-
ence ofBPA. However, ifaccessory cell-depleted progenitors are
used as target cells, the simple maneuver ofdelaying the addition
ofEP until day 3 can obviate this problem by eliminating BFU-
E responsive to EP alone. A subset of (presumably) less mature
BFU-E then show a typical dose response to increasing concen-
trations of Mo/GCT CM, and provide a sensitive BFU-E pop-
ulation for BPA assay. We have recently used this assay to show
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that highly purified recombinant GM-CSF, cloned from the Mo
cell line, has significant BPA (6).
The availability of recombinant GM-CSF and EP, and en-
riched progenitors, has made it possible to reexamine the ques-
tion of whether EP can act as an instructive molecule and in-
fluence progenitor commitment toward erythropoiesis at the ex-
pense ofgranulopoiesis, as suggested by van Zant and Goldwasser
(36, 37). Our results do not support this view, since the frequency
ofCFU-GM-derived colonies was constant despite a wide vari-
ation in EP concentration and resultant erythroid colonies.
In conclusion, the ability to obtain highly enriched human
bone marrow progenitors using a relatively simple method will
be valuable for investigating the regulation of hemopoiesis at a
cellular level. This will be particularly relevant as more highly
purified and recombinant human growth factors become avail-
able. The ability to assay more accurately for BPA, and for BPA
and erythropoietin-responsive progenitors, should allow an im-
proved evaluation of these parameters in hypoplastic anemias
and myeloproliferative disorders, and thereby offer opportunities
to gain further insight into their pathophysiology and effective
treatment.
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